Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism

Archives of Pharmacal Research

Volumn 22, Issue 3, 1999, Pages 232-236

  Jin, Ying Hua ^a   Lee, Suk Jin ^a   Chung, Myung Hee ^a   Park, Jeong Hill ^a   Park, Young In ^b   Cho, Tae Hyeong ^c   Lee, Seung Ki ^a  

^a Seoul National University   (South Korea)

^b Korea University   (South Korea)

^c Namyang Aloe Bio science Research Institute   (South Korea)

Author keywords

Aloesin; Arbutin; Synergistic tyrosinase inhibitors

Indexed keywords

ALOESIN; ARBUTIN; CHROMONE DERIVATIVE; ENZYME INHIBITOR; GLUCOSIDE; MONOPHENOL MONOOXYGENASE;

AGARICALES; ARTICLE; BINDING COMPETITION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; HUMAN; MELANOMA; METABOLISM;

AGARICALES; ARBUTIN; BINDING, COMPETITIVE; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; GLUCOSIDES; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; TUMOR CELLS, CULTURED;

EID: 0033143896     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976355     Document Type: Article

References (15)

1. Funayama, M., Arakawa, H., Yamamoto, R., Nishino, T., Shin, T. and Murao, S., Effects of alpha-and beta-arbutin on activity of tyrosinases mushroom and mouse melanoma (1995) Biosci Biotechnol Biochem., 59(1), 143-144 (1995)
2. Lerch, K., Monophenol monooxygenase from Neurospora crassa. Methods Enzymol., 142, 165-169 (1987).
3. Maeda, K. and Fukuda, M., In vitro effectiveness of several whitening cosmetic components in human melanocytes J. Soc. Chem., 42, 361-368 (1991).
4. Maeda, K., Fukuda, M., Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther., 276(2), 765-769 (1996).
5. Mason, H. S., Annu. Rev. Bichem., 34, 595-634 (1965).
6. Mishima, Y., Hatta, S., Ohyama, Y. and Inazu, M. Induction of melanogenesis suppression: cellular pharmacology and mode of differential action Pigment Cell Res., 1(6), 367-374 (1988).
7. Morrison, M. E., Yagi, M. J., Cohen G., In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci USA, 82(9), 2960-4 (1985)
8. Okabe, S., Takeuchi, R., Urushidani, T. and Murata, T., Effects of aluminum hydroxide- magnesium oxide(AH MO), Dicyclomine HCL and AH-MO+Dicyclomine HCL on acute gastric ulcers in experimental animals Applied Pharmacology (Japan), 12(5), 759-764 (1976).
9. Pawelek, J. M., Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol., 66(4), 201-209 Review (1976).
10. Pomerantz, S. H., Separation, Purification, and Properties of Two Tyrosinases from Hamster Melanoma J. Biol. Chem., 238, 2351-2357 (1963).
11. Robert, C., Hider and Lerch, K., The inhibition of tyrosinase by pyridinones Biochem. J., 257, 289-290 (1989).
12. Shirota, S., Miyazaki, K., Aiyama, R., Ichioka, M. and Yokokura, Tyrosinase inhibitors from crude drugs. Biol Pharm Bull., 17(2), 266-9 (1994).
13. Smith, C. J., OHare, K. B., Allen, J. C., Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content Pigment. Cell Res., 1(6), 386-389 (1988).
14. Wittbjer, A., Odh, G., Rosengren, A. M., Rosengren, E. and Rorsman, H., Isolation of soluble tyrosinase from human melanoma cells Acta. Derm. Venereol., 70(4), 291-294 (1990).
15. Yagi, A., Kanbara, T. and Morinove, N., Inhibition of mushroom-tyrosinase by Aloe extract Planta Medica., 515-517 (1987).